155 related articles for article (PubMed ID: 36421359)
21. Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.
Ecker BL; Vollmer CM; Behrman SW; Allegrini V; Aversa J; Ball CG; Barrows CE; Berger AC; Cagigas MN; Christein JD; Dixon E; Fisher WE; Freedman-Weiss M; Guzman-Pruneda F; Hollis RH; House MG; Kent TS; Kowalsky SJ; Malleo G; Salem RR; Salvia R; Schmidt CR; Seykora TF; Zheng R; Zureikat AH; Dickson PV
JAMA Surg; 2019 Aug; 154(8):706-714. PubMed ID: 31141112
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic factors in adenocarcinoma of the ampulla of Vater].
Fernández Aceñero MJ; Martínez Useros J; Díez-Valladares L; Ortega-Medina L; Pérez Aguirre E; de la Serna Esteban S; García Botella S; Díaz Del Arco C
Rev Esp Patol; 2018; 51(4):210-215. PubMed ID: 30269771
[TBL] [Abstract][Full Text] [Related]
23. Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater.
Todoroki T; Koike N; Morishita Y; Kawamoto T; Ohkohchi N; Shoda J; Fukuda Y; Takahashi H
Ann Surg Oncol; 2003 Dec; 10(10):1176-83. PubMed ID: 14654474
[TBL] [Abstract][Full Text] [Related]
24. Tumor-related factors and patient's age influence survival after resection for ampullary adenocarcinoma.
Barauskas G; Gulbinas A; Pranys D; Dambrauskas Z; Pundzius J
J Hepatobiliary Pancreat Surg; 2008; 15(4):423-8. PubMed ID: 18670845
[TBL] [Abstract][Full Text] [Related]
25. Preoperative platelet-to-lymphocyte ratio is a predictor of prognosis in patients with ampullary carcinoma.
Demirci NS; Ozdemir NY; Erdem GU; Bozkaya Y; Yazici O; Zengin N
Bratisl Lek Listy; 2018; 119(3):180-186. PubMed ID: 29536748
[TBL] [Abstract][Full Text] [Related]
26. Predictive factors of severe complications for ampullary, bile duct and duodenal cancers following pancreaticoduodenectomy: Multivariate analysis of a 10-year multicentre retrospective series.
Bourgouin S; Ewald J; Mancini J; Moutardier V; Delpero JR; Le Treut YP
Surgeon; 2017 Oct; 15(5):251-258. PubMed ID: 26711559
[TBL] [Abstract][Full Text] [Related]
27. Pancreatoduodenectomy associated complications influence cancer recurrence and time interval to death.
van der Gaag NA; Harmsen K; Eshuis WJ; Busch ORC; van Gulik TM; Gouma DJ
Eur J Surg Oncol; 2014 May; 40(5):551-558. PubMed ID: 24388408
[TBL] [Abstract][Full Text] [Related]
28. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection.
Qiao QL; Zhao YG; Ye ML; Yang YM; Zhao JX; Huang YT; Wan YL
World J Surg; 2007 Jan; 31(1):137-43; discussion 144-6. PubMed ID: 17171495
[TBL] [Abstract][Full Text] [Related]
29. The prognostic significance of inflammation-based scores in patients with ampullary carcinoma after pancreaticoduodenectomy.
Sun S; He C; Wang J; Huang X; Wu J; Li S
BMC Cancer; 2020 Oct; 20(1):981. PubMed ID: 33036573
[TBL] [Abstract][Full Text] [Related]
30. Very early recurrence following pancreaticoduodenectomy in patients with ampullary cancer.
Park HM; Park SJ; Han SS; Hong SK; Hong EK; Kim SW
Medicine (Baltimore); 2019 Nov; 98(44):e17711. PubMed ID: 31689805
[TBL] [Abstract][Full Text] [Related]
31. Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater.
Cloyd JM; Wang H; Overman M; Zhao J; Denbo J; Prakash L; Kim MP; Shroff R; Javle M; Varadhachary GR; Fogelman D; Wolff RA; Koay EJ; Das P; Maitra A; Aloia TA; Vauthey JN; Fleming JB; Lee JE; Katz MHG
Ann Surg Oncol; 2017 Jul; 24(7):2031-2039. PubMed ID: 28124275
[TBL] [Abstract][Full Text] [Related]
32. Impact of perioperative blood transfusion on oncological outcomes in ampullary carcinoma patients underwent pancreaticoduodenectomy.
Fei H; Zhang XJ; Sun CY; Li Z; Li ZF; Guo CG; Zhao DB
World J Gastrointest Surg; 2023 Jul; 15(7):1363-1374. PubMed ID: 37555106
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors and benefits of adjuvant therapy for ampullary cancer following pancreatoduodenectomy: A systematic review and meta-analysis.
Zhou YM; Liao S; Wei YZ; Wang SJ
Asian J Surg; 2020 Dec; 43(12):1133-1141. PubMed ID: 32249101
[TBL] [Abstract][Full Text] [Related]
34. Carcinoma of the ampulla of Vater.
Yamaguchi K; Nagai E; Ueki T; Nishihara K; Tamaka M
Aust N Z J Surg; 1993 Apr; 63(4):256-62. PubMed ID: 7906119
[TBL] [Abstract][Full Text] [Related]
35. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
Tsao JI; Rossi RL; Lowell JA
Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
[TBL] [Abstract][Full Text] [Related]
36. Prediction of tumor recurrence and poor survival of ampullary adenocarcinoma using preoperative clinical and CT findings.
Yoen H; Kim JH; Hur BY; Ahn SJ; Jeon SK; Choi SY; Lee KB; Han JK
Eur Radiol; 2021 Apr; 31(4):2433-2443. PubMed ID: 33000305
[TBL] [Abstract][Full Text] [Related]
37. Ampullary cancer and preoperative jaundice: possible indication of the minimal surgery.
Uchida H; Shibata K; Iwaki K; Kai S; Ohta M; Kitano S
Hepatogastroenterology; 2009; 56(93):1194-8. PubMed ID: 19760968
[TBL] [Abstract][Full Text] [Related]
38. Intraoperative allogeneic red blood cell transfusion in ampullary cancer outcome after curative pancreatoduodenectomy: a clinical study and meta-analysis.
Yao HS; Wang Q; Wang WJ; Hu ZQ
World J Surg; 2008 Sep; 32(9):2038-46. PubMed ID: 18584239
[TBL] [Abstract][Full Text] [Related]
39. Prognostic role of neutrophil-to-lymphocyte ratio (NLR) in patients with operable ampullary carcinoma.
Demirci NS; Erdem GU
Bosn J Basic Med Sci; 2018 Aug; 18(3):268-274. PubMed ID: 29131967
[TBL] [Abstract][Full Text] [Related]
40. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater.
Krishnan S; Rana V; Evans DB; Varadhachary G; Das P; Bhatia S; Delclos ME; Janjan NA; Wolff RA; Crane CH; Pisters PW
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):735-43. PubMed ID: 17980502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
